Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Since histone demethylases are chemically modifiable, KDM4B and KDM6B may present as therapeutic targets for controlling MSC fate choices and lead to clues for new�treatment in metabolic bone diseases such as osteoporosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP574634.RAD0qnvnlST44CqjEEXyAIp8nrgPnZ9Fhwh6SIKTMRDoQ130_assertion description "[Since histone demethylases are chemically modifiable, KDM4B and KDM6B may present as therapeutic targets for controlling MSC fate choices and lead to clues for new�treatment in metabolic bone diseases such as osteoporosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP574634.RAD0qnvnlST44CqjEEXyAIp8nrgPnZ9Fhwh6SIKTMRDoQ130_provenance.
• NP760982.RAktt833F16wUb0t72q4zmpnPO99XRsqUUCBFH610k1nw130_assertion description "[Since histone demethylases are chemically modifiable, KDM4B and KDM6B may present as therapeutic targets for controlling MSC fate choices and lead to clues for new�treatment in metabolic bone diseases such as osteoporosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP760982.RAktt833F16wUb0t72q4zmpnPO99XRsqUUCBFH610k1nw130_provenance.
• NP229927.RAfB-CGP3VuOCX0oW1bow2m6beoPpRWHXPNzBGm4Pdesg130_assertion description "[Since histone demethylases are chemically modifiable, KDM4B and KDM6B may present as therapeutic targets for controlling MSC fate choices and lead to clues for new�treatment in metabolic bone diseases such as osteoporosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP229927.RAfB-CGP3VuOCX0oW1bow2m6beoPpRWHXPNzBGm4Pdesg130_provenance.
• NP255286.RAv53vkYCjqmsOkaOxnNLaJU_0JLw7vwiRUIuxP1WmW4Y130_assertion description "[Since histone demethylases are chemically modifiable, KDM4B and KDM6B may present as therapeutic targets for controlling MSC fate choices and lead to clues for new�treatment in metabolic bone diseases such as osteoporosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP255286.RAv53vkYCjqmsOkaOxnNLaJU_0JLw7vwiRUIuxP1WmW4Y130_provenance.
• NP495051.RAq0WY4Bj8WVNrWVGdm0JebJuAkdL2OClwz09w3AIW9WE130_assertion description "[Since histone demethylases are chemically modifiable, KDM4B and KDM6B may present as therapeutic targets for controlling MSC fate choices and lead to clues for new�treatment in metabolic bone diseases such as osteoporosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP495051.RAq0WY4Bj8WVNrWVGdm0JebJuAkdL2OClwz09w3AIW9WE130_provenance.
• NP495649.RAkCsJCJtKtrxkL5Pnc9ZS1QamARfMJi3p-YrBlXE3wMw130_assertion description "[Since histone demethylases are chemically modifiable, KDM4B and KDM6B may present as therapeutic targets for controlling MSC fate choices and lead to clues for new�treatment in metabolic bone diseases such as osteoporosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP495649.RAkCsJCJtKtrxkL5Pnc9ZS1QamARfMJi3p-YrBlXE3wMw130_provenance.
• NP598871.RAwyAaqdcU0I9L_kfxekXDSx5qaIlwim1VkI2BPOL0nDg130_assertion description "[Since histone demethylases are chemically modifiable, KDM4B and KDM6B may present as therapeutic targets for controlling MSC fate choices and lead to clues for new�treatment in metabolic bone diseases such as osteoporosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP598871.RAwyAaqdcU0I9L_kfxekXDSx5qaIlwim1VkI2BPOL0nDg130_provenance.
• NP587131.RASIUGh-2CmgTfLdmqTVfGb0eDWgqFKl1pM8OZskWJGRo130_assertion description "[Since histone demethylases are chemically modifiable, KDM4B and KDM6B may present as therapeutic targets for controlling MSC fate choices and lead to clues for new�treatment in metabolic bone diseases such as osteoporosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP587131.RASIUGh-2CmgTfLdmqTVfGb0eDWgqFKl1pM8OZskWJGRo130_provenance.
• NP232672.RA2Kzfjr2qE5DP24z-JS7z3OPIwjmm8e374RMDIpgGs0o130_assertion description "[Since histone demethylases are chemically modifiable, KDM4B and KDM6B may present as therapeutic targets for controlling MSC fate choices and lead to clues for new�treatment in metabolic bone diseases such as osteoporosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232672.RA2Kzfjr2qE5DP24z-JS7z3OPIwjmm8e374RMDIpgGs0o130_provenance.
• NP917682.RAyrpVzsVvCP0N_U5wV8AV8MvyvcQVxvjFgRZ0aCsQSVg130_assertion description "[Since histone demethylases are chemically modifiable, KDM4B and KDM6B may present as therapeutic targets for controlling MSC fate choices and lead to clues for new�treatment in metabolic bone diseases such as osteoporosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP917682.RAyrpVzsVvCP0N_U5wV8AV8MvyvcQVxvjFgRZ0aCsQSVg130_provenance.
• NP924518.RA4fk7fUnlOnCg17BMzKd4kks0-Zlz7woIUG4znMBSR9o130_assertion description "[Since histone demethylases are chemically modifiable, KDM4B and KDM6B may present as therapeutic targets for controlling MSC fate choices and lead to clues for new�treatment in metabolic bone diseases such as osteoporosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP924518.RA4fk7fUnlOnCg17BMzKd4kks0-Zlz7woIUG4znMBSR9o130_provenance.
• NP867154.RAdiNl4MTRfeOmMPY19YICsILV1H3UVpRejejldvC-OwE130_assertion description "[Since histone demethylases are chemically modifiable, KDM4B and KDM6B may present as therapeutic targets for controlling MSC fate choices and lead to clues for new�treatment in metabolic bone diseases such as osteoporosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP867154.RAdiNl4MTRfeOmMPY19YICsILV1H3UVpRejejldvC-OwE130_provenance.
• NP904237.RAWxaPWqeC_QL4vdtRb3llfM-Jw0_QoHqPCVFD3s8_Or4130_assertion description "[Since histone demethylases are chemically modifiable, KDM4B and KDM6B may present as therapeutic targets for controlling MSC fate choices and lead to clues for new�treatment in metabolic bone diseases such as osteoporosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP904237.RAWxaPWqeC_QL4vdtRb3llfM-Jw0_QoHqPCVFD3s8_Or4130_provenance.
• NP904310.RAerHKGkYDnZBN3tWZiP5t6_w_-NuFPeNrzCx_s42EI7g130_assertion description "[Since histone demethylases are chemically modifiable, KDM4B and KDM6B may present as therapeutic targets for controlling MSC fate choices and lead to clues for new�treatment in metabolic bone diseases such as osteoporosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP904310.RAerHKGkYDnZBN3tWZiP5t6_w_-NuFPeNrzCx_s42EI7g130_provenance.
• NP995768.RAeWdcQEgjOBMS104ZX-xGcE5CKrJX2vWfUsxLraCRzLE130_assertion description "[Since histone demethylases are chemically modifiable, KDM4B and KDM6B may present as therapeutic targets for controlling MSC fate choices and lead to clues for new�treatment in metabolic bone diseases such as osteoporosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP995768.RAeWdcQEgjOBMS104ZX-xGcE5CKrJX2vWfUsxLraCRzLE130_provenance.
• NP995771.RAVMbCDqwVDLkE46yv8dGYXug_EKUrrC4u0wWewxRqxmM130_assertion description "[Since histone demethylases are chemically modifiable, KDM4B and KDM6B may present as therapeutic targets for controlling MSC fate choices and lead to clues for new�treatment in metabolic bone diseases such as osteoporosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP995771.RAVMbCDqwVDLkE46yv8dGYXug_EKUrrC4u0wWewxRqxmM130_provenance.
• NP929252.RAFYwX_ZFUSUFczuxgfjwsqaWf0LICM_PO8HrJUxUsuQc130_assertion description "[Since histone demethylases are chemically modifiable, KDM4B and KDM6B may present as therapeutic targets for controlling MSC fate choices and lead to clues for new�treatment in metabolic bone diseases such as osteoporosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929252.RAFYwX_ZFUSUFczuxgfjwsqaWf0LICM_PO8HrJUxUsuQc130_provenance.
• NP995770.RAlfm-CTaJdHSy8qjHG_DTovv3oO5d6tItEZqVg9ly0Cw130_assertion description "[Since histone demethylases are chemically modifiable, KDM4B and KDM6B may present as therapeutic targets for controlling MSC fate choices and lead to clues for new�treatment in metabolic bone diseases such as osteoporosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP995770.RAlfm-CTaJdHSy8qjHG_DTovv3oO5d6tItEZqVg9ly0Cw130_provenance.
• NP995772.RAnKaiOXRs1XBuhkr1vLXxhYmmaW4qfm9mMvkVj2U5BvM130_assertion description "[Since histone demethylases are chemically modifiable, KDM4B and KDM6B may present as therapeutic targets for controlling MSC fate choices and lead to clues for new�treatment in metabolic bone diseases such as osteoporosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP995772.RAnKaiOXRs1XBuhkr1vLXxhYmmaW4qfm9mMvkVj2U5BvM130_provenance.
• NP995773.RAstSg1dMdbhUCaMp9J89QqxovETR9iwLJy9zmdPQv51s130_assertion description "[Since histone demethylases are chemically modifiable, KDM4B and KDM6B may present as therapeutic targets for controlling MSC fate choices and lead to clues for new�treatment in metabolic bone diseases such as osteoporosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP995773.RAstSg1dMdbhUCaMp9J89QqxovETR9iwLJy9zmdPQv51s130_provenance.
• NP818773.RAH_tjmcp0OmpUmN5uJ_2Q9q2iXDXeCjnYpmhcahks-MQ130_assertion description "[Since histone demethylases are chemically modifiable, KDM4B and KDM6B may present as therapeutic targets for controlling MSC fate choices and lead to clues for new�treatment in metabolic bone diseases such as osteoporosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP818773.RAH_tjmcp0OmpUmN5uJ_2Q9q2iXDXeCjnYpmhcahks-MQ130_provenance.
• NP867170.RAIiXd2T394wDJ9du0HPzsBBGszsS5aNkn5jfw1pkzX1I130_assertion description "[Since histone demethylases are chemically modifiable, KDM4B and KDM6B may present as therapeutic targets for controlling MSC fate choices and lead to clues for new�treatment in metabolic bone diseases such as osteoporosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP867170.RAIiXd2T394wDJ9du0HPzsBBGszsS5aNkn5jfw1pkzX1I130_provenance.
• NP818848.RAxnF2VFKbwpO4bDxps92rONSa_hYy3vcPn1ofNRxV9WQ130_assertion description "[Since histone demethylases are chemically modifiable, KDM4B and KDM6B may present as therapeutic targets for controlling MSC fate choices and lead to clues for new�treatment in metabolic bone diseases such as osteoporosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP818848.RAxnF2VFKbwpO4bDxps92rONSa_hYy3vcPn1ofNRxV9WQ130_provenance.
• NP868369.RA9U2mgS58glPp4FtVkFW_9w4twEwZiAheyM-vy1EKJL8130_assertion description "[Since histone demethylases are chemically modifiable, KDM4B and KDM6B may present as therapeutic targets for controlling MSC fate choices and lead to clues for new�treatment in metabolic bone diseases such as osteoporosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP868369.RA9U2mgS58glPp4FtVkFW_9w4twEwZiAheyM-vy1EKJL8130_provenance.
• NP868380.RA_HETHFRLlrQx9dL8iNNWyj1rvfB4uyFD7nPRX0Bbdic130_assertion description "[Since histone demethylases are chemically modifiable, KDM4B and KDM6B may present as therapeutic targets for controlling MSC fate choices and lead to clues for new�treatment in metabolic bone diseases such as osteoporosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP868380.RA_HETHFRLlrQx9dL8iNNWyj1rvfB4uyFD7nPRX0Bbdic130_provenance.
• NP995769.RA67t4Vy-Ox9fDyza02xDxc7yx9MOONlCCDjii7YjPEM8130_assertion description "[Since histone demethylases are chemically modifiable, KDM4B and KDM6B may present as therapeutic targets for controlling MSC fate choices and lead to clues for new�treatment in metabolic bone diseases such as osteoporosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP995769.RA67t4Vy-Ox9fDyza02xDxc7yx9MOONlCCDjii7YjPEM8130_provenance.
• NP995774.RA4XR-SNy1BEEXeM5u4hJD8oRXyYWn6oW8nMRsEq8n1Ik130_assertion description "[Since histone demethylases are chemically modifiable, KDM4B and KDM6B may present as therapeutic targets for controlling MSC fate choices and lead to clues for new�treatment in metabolic bone diseases such as osteoporosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP995774.RA4XR-SNy1BEEXeM5u4hJD8oRXyYWn6oW8nMRsEq8n1Ik130_provenance.
• NP995775.RA_5hg0jGQ22U4-YAESVDlt1XnUYC7_5fsgWrBpoe-kjY130_assertion description "[Since histone demethylases are chemically modifiable, KDM4B and KDM6B may present as therapeutic targets for controlling MSC fate choices and lead to clues for new�treatment in metabolic bone diseases such as osteoporosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP995775.RA_5hg0jGQ22U4-YAESVDlt1XnUYC7_5fsgWrBpoe-kjY130_provenance.